Phoenixus AG, the drug company founded and controlled by Martin Shkreli, has maintained a low public profile following the backlash over the Daraprim price hike and his federal conviction for securities fraud.
While Shkreli has tried to steer Phoenixus’ operations from prison, the company formerly known as Vyera Pharmaceuticals (and Turing Pharmaceuticals before that) continues to lose money due to declining sales, according to financial documents obtained by STAT.
About the Author Reprints
Phoenixus sounds like a quality employer . I feel bad about the rep who is battling cancer and dealing with job loss.
This figure is continually repeated – “and then raised the price on [Daraprim] more than 5,000%.” I am still waiting for a comment / report on what they are charging now. Remember they promised to cut the price?